TXA for GI Bleeds? The HALT-IT Trial

July 15, 2020 00:26:28
TXA for GI Bleeds?  The HALT-IT Trial
Critical Care Perspectives in Emergency Medicine
TXA for GI Bleeds? The HALT-IT Trial

Jul 15 2020 | 00:26:28

/

Show Notes

The use of tranexamic acid (TXA) has markedly increased since the results of the CRASH-II trial were published.  In addition to its use in trauma, TXA has been evaluated and used in numerous other conditions, including post-partum hemorrhage and epistaxis.  Recently, the HALT-IT Trial was published online in the Lancet, which evaluated the use of TXA in patients with acute gastrointestinal bleeding.  In this podcast we discuss the HALT-IT Trial and its implications for clinical practice. 

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode 0

December 31, 2018 00:37:34
Episode Cover

Top Articles of 2018

A plethora of great articles pertaining to the care of critically ill patients were published in 2018.  In this podcast, we review some of...

Listen

Episode 0

October 04, 2022 00:25:21
Episode Cover

Does a Restrictive Oxygenation Target Make a Difference in the Post-Arrest Patient?

The care of patients with return of spontaneous circulation following cardiac arrest centers on optimizing oxygenation and ventilation, optimizing hemodynamics, identifying patients that require...

Listen

Episode 0

October 24, 2023 00:33:10
Episode Cover

SCCM Guidelines for RSI in the Critically Ill

RSI is one of the most common procedures in critically ill patients.  Despite its frequency, there remains significant practice variation on numerous aspects of...

Listen